Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 1/20 | 0.44 |
| ▸ | GRM1 | Q13255 | 2/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | NSD2 | O96028 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17893428 | 0.89 | FFAR3 (0.38) | FFAR3GRM1CYP2C19AKR1C1 | |
| SCHEMBL9506878 | 0.89 | CYP2C19 (0.40) | FFAR3GRM1CYP2C19AKR1C1 | |
| SCHEMBL20294165 | 0.87 | FFAR3 (0.36) | FFAR3GRM1 | |
| SCHEMBL8180378 | 0.87 | NSD2 (0.38) | FFAR3GRM1CYP2C19NSD2 | |
| SCHEMBL2826212 | 0.87 | FFAR3 (0.36) | FFAR3GRM1 | |
| SCHEMBL16933182 | 0.85 | GRM1 (0.40) | FFAR3GRM1CYP2C19 | |
| SCHEMBL478303 | 0.85 | GRM1 (0.40) | FFAR3GRM1CYP2C19 | |
| SCHEMBL11714540 | 0.84 | FFAR3 (0.48) | FFAR3GRM1CYP2C19 | |
| SCHEMBL19554425 | 0.84 | FFAR3 (0.35) | FFAR3GRM1 | |
| SCHEMBL9999641 | 0.84 | FFAR3 (0.35) | FFAR3GRM1CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 244 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4642570-A2 | ACID GAS CAPTURE THROUGH METAL-LIGAND INSERTION IN POROUS MATERIALS AT ELEVATED TEMPERATURES | The Regents of the University of California (US) | 2025-11-05 | — | — | EP | claimed |
| US-20250325567-A1 | COADMINISTRATION OF POLYCANNABINOID WITH AMINE/AMIDE ANESTHETICS TO ENHANCE EFFICACY AGAINST PAIN | UNIV CONNECTICUT (US) | 2025-10-23 | — | — | US | claimed |
| US-20250296070-A1 | ACID GAS CAPTURE THROUGH METAL-LIGAND INSERTION IN POROUS MATERIALS AT ELEVATED TEMPERATURES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-09-25 | — | — | US | claimed |
| CN-119978418-A | Microporous copper-based wheel paddle binuclear metal organic framework material and application thereof in gas separation | 三峡大学 | 2025-05-13 | — | — | CN | claimed |
| US-20250122395-A1 | POLYCANNABINOIDS FOR COMMODITY POLYMERS AND COMMODITY ELECTRONICS | PURDUE RESEARCH FOUNDATION | 2025-04-17 | — | — | US | claimed |
| CN-119060458-B | Plastic product based on polypropylene and production method thereof | 江西朝晖氟塑制品有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-119060458-A | Plastic product based on polypropylene and production method thereof | 江西朝晖氟塑制品有限公司 | 2024-12-03 | — | — | CN | claimed |
| US-20240336833-A1 | POLYCANNABINOIDS FOR COMMODITY POLYMERS AND COMMODITY ELECTRONICS | UNIVERSITY OF CONNECTICUT | 2024-10-10 | — | — | US | claimed |
| CN-118307737-A | Degradable and recyclable polyether polyurethane and preparation method thereof | 华南理工大学 | 2024-07-09 | — | — | CN | claimed |
| WO-2024145655-A2 | ACID GAS CAPTURE THROUGH METAL-LIGAND INSERTION IN POROUS MATERIALS AT ELEVATED TEMPERATURES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-07-04 | — | — | WO | claimed |
| CN-116769175-A | Microporous material SDDOF-1 and preparation method and application thereof | 苏州大学 | 2023-09-19 | — | — | CN | claimed |
| WO-2023287736-A1 | NOVEL BIS-AMIDE CONTAINING COMPOUNDS EXHIBITING ANTIFUNGAL ACTIVITY AND THEIR METHOD OF USE | FOX CHASE CHEMICAL DIVERSITY CENTER, INC. (US) | 2023-01-19 | — | — | WO | claimed |
| WO-2026100662-A1 | LIQUID CRYSTAL ALIGNING AGENT AND LIQUID CRYSTAL DISPLAY ELEMENT | 日産化学株式会社 | 2026-05-15 | — | — | WO | disclosed |
| US-12528983-B2 | Curable resin composition and display device | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2026-01-20 | — | — | US | disclosed |
| US-12504564-B2 | Layered body and display device | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2025-12-23 | — | — | US | disclosed |
| US-20250348000-A1 | RESIST UNDERLAYER FILM-FORMING COMPOSITION | NISSAN CHEMICAL CORPORATION (JP) | 2025-11-13 | — | — | US | disclosed |
| US-20040067966-A1 | Adenosine receptor antagonists and methods of making and using the same | BIOGEN, INC. | 2004-04-08 | — | — | US | disclosed |
| US-6649600-B1 | 2,6-Dioxo or dithioxy-2,3,6,7-tetrahydro-1H-purin-8-yl)-bicyclo derivatives; highly potent and selective diuretics | BIOGEN, INC. | 2003-11-18 | — | — | US | disclosed |
| EP-1230243-A1 | POYCYLOALKYLPURINES AS ADENOSINE RECEPTOR ANTAGONISTS | BIOGEN, INC. (US) | 2002-08-14 | — | — | EP | disclosed |
| WO-2001034610-A1 | POLYCYCLOALKYLPURINES AS ADENOSINE RECEPTOR ANTAGONISTS | BIOGEN, INC. (US) | 2001-05-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250325567-A1 | COADMINISTRATION OF POLYCANNABINOID WITH AMINE/AMIDE ANESTHETICS TO ENHANCE EFFICACY AGAINST PAIN | CNR2, CNR1, OPRL1 | FFAR3 324/4885GRM1 233/4885CYP2C19 681/4885 |
| US-12528983-B2 | Curable resin composition and display device | TIPRL, NLRP1, RCSD1 | FFAR3 2195/4885GRM1 1296/4885CYP2C19 3476/4885 |
| US-20040067966-A1 | Adenosine receptor antagonists and methods of making and using the same | ADORA1, ADORA2A, ADORA3 | FFAR3 349/4885GRM1 387/4885CYP2C19 2149/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.